The effect of insulin infusion on the metabolites in cerebral tissues assessed with proton magnetic resonance spectroscopy in young healthy subjects with high and low insulin sensitivity

Diabetes Care

Volumn 36, Issue 9, 2013, Pages 2787-2793

  Karczewska Kupczewska, Monika ^a   Tarasów, Eugeniusz ^a   NikoŁajuk, Agnieszka ^b   Stefanowicz, Magdalena ^a   Matulewicz, Natalia ^a   Otziomek, Elzbieta ^a   Górska, Maria ^a   Straczkowski, Marek ^a,b   Kowalska, Irina ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b INSTITUTE OF ANIMAL REPRODUCTION AND FOOD RESEARCH   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; CHOLINE; CREATININE; GLUTAMIC ACID; GLUTAMINE; INOSITOL; INSULIN; N ACETYLASPARTIC ACID; WATER;

ADULT; ARTICLE; BRAIN TISSUE; COMPLEX FORMATION; CONTROLLED STUDY; FRONTAL CORTEX; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; INSULIN SENSITIVITY; MALE; METABOLIC REGULATION; METABOLITE; NEUROCHEMISTRY; NORMAL HUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; TEMPORAL LOBE; THALAMUS;

ADULT; BRAIN; HUMANS; INSULIN; INSULIN INFUSION SYSTEMS; INSULIN RESISTANCE; MAGNETIC RESONANCE SPECTROSCOPY; MALE; YOUNG ADULT;

EID: 84891757994     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-1437     Document Type: Article

References (40)

1. Roriz-Filho JS, Sá-Roriz TM, Rosset I, et al. (Pre)diabetes, brain aging, and cognition. Biochim Biophys Acta 2009;1792: 432-443
2. Brands AM, Biessels GJ, Kappelle LJ, et al.; Utrecht Diabetic Encephalopathy Study Group. Cognitive functioning and brain MRI in patients with type 1 and type 2 diabetes mellitus: a comparative study. Dement Geriatr Cogn Disord 2007;23: 343-350
3. Luchsinger JA, Tang MX, Shea S, Mayeux R. Hyperinsulinemia and risk of Alzheimer disease. Neurology 2004;63: 1187-1192
4. McCall AL. The impact of diabetes on the CNS. Diabetes 1992;41: 557-570
5. Peila R, Rodriguez BL, Launer LJ;Honolulu- Asia Aging Study. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes 2002;51: 1256-1262
6. MacKnight C, Rockwood K, Awalt E, McDowell I. Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging. Dement Geriatr Cogn Disord 2002;14: 77-83
7. Yau PL, Javier DC, Ryan CM, et al. Preliminary evidence for brain complications in obese adolescents with type 2 diabetes mellitus. Diabetologia 2010;53: 2298-2306
8. Bondy CA, Cheng CM. Signaling by insulin-like growth factor 1 in brain. Eur J Pharmacol 2004;490: 25-31
9. Plum L, Belgardt BF, Brüning JC. Central insulin action in energy and glucose homeostasis. J Clin Invest 2006;116: 1761-1766
10. Zhao WQ, Chen H, Quon MJ, Alkon DL. Insulin and the insulin receptor in experimental models of learning and memory. Eur J Pharmacol 2004;490: 71-81
11. McNay EC, Ong CT, McCrimmon RJ, Cresswell J, Bogan JS, Sherwin RS. Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance. Neurobiol Learn Mem 2010;93: 546-553
12. Benedict C, Hallschmid M, Hatke A, et al. Intranasal insulin improves memory in humans. Psychoneuroendocrinology 2004; 29: 1326-1334
13. Kern W, Peters A, Fruehwald-Schultes B, Deininger E, Born J, Fehm HL. Improving influence of insulin on cognitive functions in humans. Neuroendocrinology 2001; 74: 270-280
14. de la Monte SM. Insulin resistance and Alzheimer's disease. BMB Rep 2009;42: 475-481
15. Janson J, Laedtke T, Parisi JE, O'Brien P, Petersen RC, Butler PC. Increased risk of type 2 diabetes in Alzheimer disease. Diabetes 2004;53: 474-481
16. Rutgers DR, Klijn CJ, Kappelle LJ, van der Grond J. Cerebral metabolic changes in patients with a symptomatic occlusion of the internal carotid artery: a longitudinal 1H magnetic resonance spectroscopy study. J Magn Reson Imaging 2000;11: 279-286
17. Duarte JM, Lei H, Mlynárik V, Gruetter R. The neurochemical profile quantified by in vivo 1H NMR spectroscopy. Neuroimage 2012;61: 342-362
18. Miller BL, Chang L, Booth R, et al. In vivo 1H MRS choline: correlation with in vitro chemistry/histology. Life Sci 1996;58: 1929-1935
19. Katz-Brull R, Koudinov AR, Degani H. Direct detection of brain acetylcholine synthesis by magnetic resonance spectroscopy. Brain Res 2005;1048: 202-210
20. Fisher SK, Novak JE, Agranoff BW. Inositol and higher inositol phosphates in neural tissues: homeostasis, metabolism and functional significance. J Neurochem 2002;82: 736-754
21. Hall H, Cuellar-Baena S, Dahlberg C, In't Zandt R, Denisov V, Kirik D. Magnetic resonance spectroscopic methods for the assessment of metabolic functions in the diseased brain. Curr Top Behav Neurosci 2012;11: 169-198
22. Meldrum BS. Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J Nutr 2000;130(Suppl.): 1007S-1015S
23. Shank RP, Bennett DJ. 2-Oxoglutarate transport: a potential mechanism for regulating glutamate and tricarboxylic acid cycle intermediates in neurons. Neurochem Res 1993;18: 401-410
24. Ben-Ari Y, Gaiarsa JL, Tyzio R, Khazipov R. GABA: a pioneer transmitter that excites immature neurons and generates primitive oscillations. Physiol Rev 2007; 87: 1215-1284
25. Martin WR. MR spectroscopy in neurodegenerative disease. Mol Imaging Biol 2007;9: 196-203
26. Ross AJ, Sachdev PS. Magnetic resonance spectroscopy in cognitive research. Brain Res Brain Res Rev 2004;44: 83-102
27. Duarte JM, Carvalho RA, Cunha RA, Gruetter R. Caffeine consumption attenuates neurochemical modifications in the hippocampus of streptozotocin-induced diabetic rats. J Neurochem 2009;111: 368-379
28. Sahin I, Alkan A, Keskin L, et al. Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus. J Diabetes Complications 2008;22: 254-260
29. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214- E223
30. Ferrannini E, Mari A. How to measure insulin sensitivity. J Hypertens 1998;16: 895-906
31. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of lowdensity lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18: 499-502
32. Kario K, Matsuo T, Hoshide S, Umeda Y, Shimada K. Effect of thrombin inhibition in vascular dementia and silent cerebrovascular disease. An MR spectroscopy study. Stroke 1999;30: 1033-1037
33. Tschritter O, Preissl H, Hennige AM, et al. The cerebrocortical response to hyperinsulinemia is reduced in overweight humans: a magnetoencephalographic study. ProcNatl Acad Sci USA 2006;103: 12103-12108
34. Bartha R, Williamson PC, Drost DJ, et al. Measurement of glutamate and glutamine in the medial prefrontal cortex of nevertreated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy. Arch Gen Psychiatry 1997;54: 959-965
35. Rotte M, Baerecke C, Pottag G, et al. Insulin affects the neuronal response in the medial temporal lobe in humans. Neuroendocrinology 2005;81: 49-55
36. Ross BD, Bluml S, Cowan R, Danielsen E, Farrow N, Gruetter R. In vivo magnetic resonance spectroscopy of human brain: the biophysical basis of dementia. Biophys Chem 1997;68: 161-172
37. Ackl N, Ising M, Schreiber YA, Atiya M, Sonntag A, Auer DP. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease. Neurosci Lett 2005;384: 23-28
38. Kreis R, Ross BD. Cerebral metabolic disturbances in patients with subacute and chronic diabetes mellitus: detection with proton MR spectroscopy. Radiology 1992;184: 123-130
39. Schulingkamp RJ, Pagano TC, Hung D, Raffa RB. Insulin receptors and insulin action in the brain: review and clinical implications. Neurosci Biobehav Rev 2000;24: 855-872
40. Talbot K, Wang HY, Kazi H, et al. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest 2012;122: 1316-1338